Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Qualigen Therapeutics Inc (QLGN)  
$0.44 0.00 (0.00%) as of 4:30 Tue 6/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 1,460,000
Market Cap: 642.40(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.44 - $0.44
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Qualigen Therapeutics is a life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics. Co.'s drug compound QN-302 is being developed to target regulatory regions of cancer genes that down-regulate gene expression in multiple cancer pathways. Co.'s anticancer drug candidate, QN-247 is aptamer-based and in development to treat a variety of cancer types, including liquid and solid tumors. Co.'s RAS-F portfolio is designed to suppress the interaction of endogenous RAS with c-RAF, upstream of the KRAS, HRAS and NRAS effector pathways.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 10
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Poirier Michael S. Chairman and CEO   •       •      –    2022-06-22 4 B $0.57 $17,100 D/D 30,000 199,202 2.81     -
   Broidrick Amy S. President/CSO   •       •      –    2022-06-14 4 B $0.62 $18,600 D/D 30,000 34,500 2.81     -
   Kruger Kurt H Director   –       •      –    2021-08-19 4 B $1.22 $9,800 D/D 8,000 18,000 2.39     -
   Broidrick Amy S. EVP, Chief Strategy Officer   •       •      –    2021-04-26 4 B $2.03 $9,135 D/D 4,500 4,500 2.81     -
   Poirier Michael S. Chairman, CEO & President   •       •      –    2021-04-20 4 B $1.80 $19,809 I/I 11,005 11,005 2.58     -
   Lotz Christopher L. Vice President of Finance, CFO   •       –      –    2021-04-16 4 B $1.86 $5,022 D/D 2,700 12,541 2.74     -
   Kruger Kurt H Director   –       •      –    2020-12-29 4 B $2.94 $11,740 D/D 4,000 10,000 2.39     -
   Emery Sidney W Jr Director   –       •      –    2020-12-07 3 IO $0.00 $0 D/D 0 19,682     -
   Kruger Kurt H Director   –       •      –    2020-11-23 4 B $3.46 $15,925 D/D 4,600 6,000 2.39     -
   Kruger Kurt H Director   –       •      –    2020-11-20 4 B $3.55 $4,969 D/D 1,400 1,400 2.31     -

  10 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed